Last update July 3, 2022
Very Low Risk
It is a reuptake-inhibitor of Serotonin and Norepinephrine, and active metabolite of Venlafaxine. Oral administration once a day.
It is excreted in low amount into breast milk. (Ilett 2010, Rampono 2004).
The amount detected in the infant's plasma is in the range of 2% - 6% respective to the amount found in the mother's plasma. (Ilett 2010, Rampono 2004).
Not relevant side-effects have been found in such infants. (Keightley 2020, Rampono 2004)
It is very rare that it causes increased prolactin levels and/or galactorrhea. (Tourian 2011)
Various medical societies and expert consensus consider the use of this medication compatible with breastfeeding. (Hale, Rowe 2013).
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.